ARDS, Human: Clinical Trials

2 trials for ARDS, Human, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated, 1 unknown. 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 12Terminated 1, Unknown 1

Follow ARDS, Human: new trials by email Literature Review of ARDS, Human trials Research Report on ARDS, Human

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety Evaluation of BZ371B in ARDS Patients
Inhaled BZ371B - ARDS, ARDS, Human
Early Phase 1TerminatedBiozeus Biopharmaceutical S.A.12022-11-232023-06-01
Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19
Mesenchymal Stem Cells derived from Wharton Jelly of Umbilical cords - ARDS, Human, Covid-19
Early Phase 1UnknownInstituto de Medicina Regenerativa92020-04-162024-03-06

Narrower conditions

Respiratory Distress Syndrome (2)  ·  COVID-19 (1)  ·  Lung Diseases (1)

Broader conditions

Respiration Disorders (2)  ·  Respiratory Tract Diseases (2)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Nidovirales Infections (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Infections (1)  ·  Virus Diseases (1)

Sponsors

Biozeus Biopharmaceutical S.A. (1)  ·  Instituto de Medicina Regenerativa (1)

Countries

Brazil (1)  ·  Mexico (1)

Top investigators

Jesus Perez (1)  ·  Juan Parcero (1)  ·  Marcelo BP Amato, Phd (1)